Register

COURSE DESCRIPTION:  

Please join us for “Multiple Sclerosis Update 2025” with Amy W. Laitinen, M.D.
Dr. Laitinen will appraise the current approaches to MS disease modifying treatments (DMT) and explain what the trajectory of a patient diagnosed with MS in the modern age may entail.

TARGET AUDIENCE:

Internal Medicine Physicians, Cardiologists, Pharmacists, Physician Assistants, Residents, Advanced Practice Registered Nurses, Medical Students, and all other interested healthcare providers

LEARNING OBJECTIVES:

• Discuss the basic epidemiology and the diagnostic criteria for multiple sclerosis.
• Examine the new paraclinical tools used in MS.
• Appraise the current approaches to MS disease modifying treatments (DMT).
• Explain what the trajectory of a patient diagnosed with MS in the modern age may entail.

FACULTY AND DISCLOSURES:  

Amy Wei-Hsin Laitinen (nee Yu), M.D.
Medical Director, Multiple Sclerosis and Neuroimmunology 
Marcus Neuroscience Institute
Baptist Health – Boca Raton Regional Hospital
Boca Raton, Florida

Amy Wei-Hsin Laitinen (nee Yu), M.D., faculty for this educational activity, is a consultant for Roche, Genentech, Horizon Therapeutics/Amgen and TG Therapeutics, and has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed have been mitigated.

G. Peter Gliebus, M.D., director for this educational event, is a speaker for Eisai CO., Ltd.  All of the relevant financial relationship listed for this individual have been mitigated.

Kendra Kent, M.S., R.N., CENP, CCRN, SCRN, CNRN, TCRN, planner for this educational event, has no relevant financial relationships with ineligible companies* to disclose.

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships with ineligible companies to disclose.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians. Baptist Health has been re-surveyed by the ACCME and awarded Commendation for 6 years as a provider of CME for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-1195520, by the Florida Boards of Medicine, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Occupational Therapists, Dietitians and Respiratory Therapists. Baptist Health South Florida CE Broker Provider #50-182.